The table below shows Sarepta Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Revenue
$730.80M
$442.93M
$399.36M
$611.09M
$744.86M
$658.41M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-$29.10M
$219.27M
$360.56M
$473.96M
$505.85M
R&D
-
-
-
-
-
-
SRPT annual revenue (10-K history)
Sarepta Therapeutics, Inc. reported annual revenue of $2.20B for fiscal year 2025. That is up 15.6% from $1.90B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $5.42M (FY 2016) to $2.20B. Figures come from the company's audited annual reports as filed with the SEC.
